Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Immunomedics, Inc. (NQ: IMMU)
3.360 USD  +0.080 (+2.44%)
Official Closing Price  /  Updated: 5:20 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Immunomedics, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Commit To Purchase Immunomedics At $2, Earn 22.8% Annualized
May 23, 2013
Investors considering a purchase of Immunomedics, Inc. (IMMU) shares, but cautious about paying the going market price of $3.27/share, might benefit from considering selling puts among the alternative... Read More
category Stocks
from Market News Video
Commit To Purchase Immunomedics At $2, Earn 22.8% Annualized
May 23, 2013
Investors considering a purchase of Immunomedics, Inc. (IMMU) shares, but cautious about paying the going market price of $3.27/share, might benefit from considering selling puts among the alternative... Read More
category Dividends
from Dividend Channel
Traders Get Bullish on Shares of Immunomedics, Shares Up 8.1% (IMMU)
May 13, 2013
from Comtex SmarTrend® News Briefs
Immunomedics, Inc. (IMMU) Swings to Q3 Profit
May 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8319141 for the full story. Read More
from StreetInsider.com News Articles
Immunomedics Announces Third Quarter Fiscal 2013 Results and Clinical Program Developments
May 08, 2013
from GlobeNewswire News Releases
Immunomedics Reports Three New Patent Wins
May 07, 2013
Immunomedics, Inc. (Nasdaq: IMMU ), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other... Read More
category Benzinga , News , IMMU
from Latest Articles from Benzinga.com
Immunomedics Announces Three New Patent Awards
May 07, 2013
The Company Ranked Tenth in the World for US Patents in Biotechnology/Pharmaceuticals Read More
from GlobeNewswire News Releases
Immunomedics Announces Conference Call and Webcast for Third Quarter Fiscal 2013 Financial Results
April 25, 2013
from GlobeNewswire News Releases
Immunomedics (IMMU) Updates on Preclinical Data for T-cell Redirecting Agent Development
April 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8244184 for the full story. Read More
from StreetInsider.com News Articles
Immunomedics Develops T-Cell Redirecting Bispecific Antibodies as Potential Therapeutics for Solid and Liquid Tumors
April 10, 2013
Immunomedics, Inc. (Nasdaq: IMMU ), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other... Read More
category Benzinga , News , IMMU
from Latest Articles from Benzinga.com
Immunomedics Develops T-Cell Redirecting Bispecific Antibodies as Potential Therapeutics for Solid and Liquid Tumors
April 10, 2013
Mechanism of Action Study on Epratuzumab Also Reported Read More
from GlobeNewswire News Releases
Immunomedics Announces First Results of Labetuzumab-SN-38 in Colorectal Cancer Study
April 09, 2013
Immunomedics, Inc. (Nasdaq: IMMU ), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other... Read More
category Benzinga , News , FDA , and 1 more.
from Latest Articles from Benzinga.com
Verenium Corporation (NASDAQ:VRNM), Immunomedics Inc. (NASDAQ:IMMU), and Obagi Medical Products, Inc. (NASDAQ:OMPI) Added to Equity Profile Report's NASDAQ Decliners Watch List.
April 09, 2013
New York, NY -- (SBWIRE) -- 04/09/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Verenium Corporation (NASDAQ:VRNM), Immunomedics Inc. (NASDAQ:IMMU), and Obagi... Read More
from SBWire - Latest Press Releases
Immunomedics Reports First Results of Labetuzumab-SN-38 in Colorectal Cancer
April 09, 2013
Results Presented as Late-Breaking Poster at 2013 Annual Meeting of the American Association for Cancer Research Read More
from GlobeNewswire News Releases
Immunomedics Creates Novel Antibody-Cytokine Conjugates for Cancer Therapy
April 08, 2013
from GlobeNewswire News Releases
Immunomedics (IMMU) Reports Dlivatuzumab Reactive with PDAC, Not CP Tissues
April 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8238975 for the full story. Read More
from StreetInsider.com News Articles
Immunomedics Announces Clivatuzumab-Based Blood Test Can Differentiate Between Pancreatic Cancer and Chronic Pancreatitis
April 08, 2013
from GlobeNewswire News Releases
Top Gainers Trade Data on Share Market - TCCO, COVR, IMMU, CLIR
April 03, 2013
New York, NY -- (SBWIRE) -- 04/03/2013 -- Pennystockparlay.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We... Read More
from SBWire - Latest Press Releases
Free Research Reports on AVGO, HUM, IMMU and TIBX Issued by the Bedford Report
April 03, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
NASDAQ Gainers Watch List: Immunomedics Inc. (NASDAQ:IMMU) and GenMark Diagnostics, Inc. (NASDAQ:GNMK) Added to Growing Stock Report's NASDAQ Gainers Watch List.
April 02, 2013
New York, NY -- (SBWIRE) -- 04/02/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Immunomedics Inc. (NASDAQ:IMMU) and GenMark Diagnostics, Inc. (NASDAQ:GNMK). Read More
from SBWire - Latest Press Releases
Immunomedics Settles FINRA Arbitration Proceedings, to Receive Gross Settlement of $18M
April 01, 2013
Immunomedics, Inc. (Nasdaq: IMMU ), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other... Read More
category Benzinga , News , Legal , and 1 more.
from Latest Articles from Benzinga.com
Immunomedics Settles Finra Arbitration Proceedings Relating to Its Prior Investment in Certain Securities
April 01, 2013
from GlobeNewswire News Releases
Immunomedics Announces Presentations at the 2013 Annual Meeting of the American Association for Cancer Research
April 01, 2013
from GlobeNewswire News Releases
NASDAQ Decliners Watch List: Halozyme Therapeutics, Inc. (NASDAQ:HALO), Cell Therapeutics, Inc. (NASDAQ:CTIC), Cytori Therapeutics, Inc. (NASDAQ:CYTX), and Immunomedics Inc. (NASDAQ:IMMU) Added to Gro
March 28, 2013
New York, NY -- (SBWIRE) -- 03/28/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Halozyme Therapeutics, Inc. (NASDAQ:HALO), Cell Therapeutics, Inc. (NASDAQ:CTIC),... Read More
from SBWire - Latest Press Releases
Xenoport, Inc. (NASDAQ:XNPT), Immunomedics Inc. (NASDAQ:IMMU), and Cynosure, Inc. (NASDAQ:CYNO) Added to Growing Stock Report's NASDAQ Decliners Watch List.
March 21, 2013
New York, NY -- (SBWIRE) -- 03/21/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Xenoport, Inc. (NASDAQ:XNPT), Immunomedics Inc. (NASDAQ:IMMU), and Cynosure, Inc.... Read More
from SBWire - Latest Press Releases
4 Pharma Stocks to Sell
March 06, 2013
 Read More
category NASDAQ:IMMU , NYSE:NVO , NYSE:AZN , and 1 more.
from InvestorPlace - Latest Headlines
Immunomedics Announces Closing of Public Offering and Full Exercise of Overallotment Option by Underwriters
February 27, 2013
from GlobeNewswire News Releases
Stocks to Watch: Frontline Ltd., Immunomedics, Inc., Corelogic Inc, Rentech Nitrogen Partners LP
February 25, 2013
Lakeway, TX -- (SBWIRE) -- 02/25/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
Immunomedics to Present at Cowen and Company 33rd Annual Health Care Conference
February 25, 2013
from GlobeNewswire News Releases
U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous
February 25, 2013
RDInvesting Provides Stocks Research on Cardium Therapeutics and Immunomedics Read More
from Marketwired News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here